Background: Uncontrolled acute postoperative pain is considered a risk factor for the development of chronic pain afterward. Objectives: To explore the most effective dose of ketamine instillation (1 of 3 doses: 1, 2, or 3 mg/kg) for acute and chronic post mastectomy pain (PMP). Methods: Ninety female patients with cancer breast, aged (18 - 60 yrs), weighted (50 - 90 kg), scheduled for modified radical mastectomy, randomly allocated into 3 groups to receive ketamine instillation after surgical homeostasis before wound closure (1 of 3 doses; 1, 2, or 3 mg/kg as A, B or C groups respectively) patients were followed up for 48 h for acute pain (total morphine consumption, the first request of analgesia and visual analog scale at rest and movement (VASR/M), chronic pain by Leeds assessment of neuropathic signs and symptoms (LANSS) for six-months, hemodynamics, and side effects. Results: Median total dose of morphine consumption was 8 mg (5 - 10) versus 6 mg (6 - 7) in A and B groups respectively in the first 48 h postoperatively. Lowest VASR/M was recorded in C then B and lastly A group (P = 0.037). No patients in the C group requested analgesia versus thirty (100%) and nine (30%) patients in the A and B groups respectively with the first request of analgesia was 12 h (5 - 36) in the A group versus 30 h (12 - 36) in the B group respectively (P < 0.001). In the three studied groups, no patients in the C group had neuropathic pain versus 2 and 9 patients in B and A groups respectively (P ≤ 0.001) without serious side effects. Conclusion: Ketamine instillation effectively controlled acute post mastectomy pain (PMP) in a dose-dependent manner and reduced the incidence and severity of chronic pain in patients who undergoing a modified radical mastectomy.
References
[1]
Rietman, J.S., Dijkstra, P.U., Debreczeni, R., Geertzen, J.H., Robinson, D.P. and De Vries, J. (2004) Impairments, Disabilities, and Health-Related Quality of Life after Treatment for Breast Cancer: A Follow-Up Study 2.7 Years after Surgery. Disability and Rehabilitation, 26, 78-84. https://doi.org/10.1080/09638280310001629642
[2]
Poleshuck, E.L., Katz, J., Andrus, C.H., Hogan, L.A., Jung, B.F., Kulick, D., et al. (2006) Risk Factors for Chronic Pain Following Breast Cancer Surgery: A Prospective Study. The Journal of Pain, 7, 626-634. https://doi.org/10.1016/j.jpain.2006.02.007
[3]
Stevens, P.E., Dibble, S.L. and Miakowski, C. (1995) Prevalence, Characteristics, and Impact of Postmastectomy Pain Syndrome: An Investigation of Women’s Experiences. Pain, 61, 61-68. https://doi.org/10.1016/0304-3959(94)00162-8
[4]
Rowbotham, M.C., Davies, P.S., Verkempinck, C. and Galer, B.S. (1996) Lidocaine Patch: A Double-Blind Placebo-Controlled Study of a New Treatment Method for Post Herpetic Neuralgia. Pain, 65, 39-44. https://doi.org/10.1016/0304-3959(95)00146-8
[5]
Chang, S.H., Mehta, V. and Langford, R.M. (2009) Acute and Chronic Pain following Breast Surgery. Acute Pain, 11, 1-14. https://doi.org/10.1016/j.acpain.2009.01.001
[6]
Jonnavithula, N., Khandelia, H., Durga, P. and Ramachandran, G. (2015) Role of Wound Instillation with Bupivacaine through Surgical Drains for Postoperative Analgesia in Modified Radical Mastectomy. Indian Journal of Anaesthesia, 59, 15-20. https://doi.org/10.4103/0019-5049.149443
[7]
Agarwal, A., Gupta, D., Kumar, M., Dhiraaj, S., Tandon, M. and Singh, P.K. (2006) Ketamine for Treatment of Catheter-Related Bladder Discomfort: A Prospective, Randomized, Placebo-Controlled, and Double-Blind Study. British Journal of Anaesthesia, 96, 587-589. https://doi.org/10.1093/bja/ael048
[8]
Galer, B.S., Jensen, M.P., Ma, T., Davies, P.S. and Rowbotham, M.C. (2002) The Lidocaine Patch 5% Effectively Treats All Neuropathic Pain Qualities: Results of a Randomized, Double-Blind, Vehicle-Controlled, 3-Week Efficacy Study with the Use of the Neuropathic Pain Scale. The Clinical Journal of Pain, 18, 297-301. https://doi.org/10.1097/00002508-200209000-00004
[9]
Abd EL-Rahman, A. and El Sherif, F. (2018) Efficacy of Postoperative Analgesia of Local Ketamine Wound Instillation Following Total Thyroidectomy; A Randomized, Double-Blind, Controlled Clinical Trial. The Clinical Journal of Pain, 34, 53-58. https://doi.org/10.1097/AJP.0000000000000521
[10]
Bennett, M. (2001) The LANSS Pain Scale, the Leeds Assessment of Neuropathic Symptoms and Signs. Pain, 92, 147-157. https://doi.org/10.1016/S0304-3959(00)00482-6
[11]
Watkins, L.R., Wiertelak, E.P., Goehler, L.E., Smith, K.P., Martin, D. and Maier, S.F. (1994) Characterization of Cytokine-Induced Hyperalgesia. Brain Research, 654, 15-26. https://doi.org/10.1016/0006-8993(94)91566-0
[12]
Sawynok, J. (2014) Topical and Peripheral Ketamine as an Analgesic. Anesthesia & Analgesia, 119, 170-178. https://doi.org/10.1213/ANE.0000000000000246
[13]
Kinkelin, I., Brocker, E.B., Koltzenburg, M. and Carlton, M.S. (2000) Localization of Ionotropic Glutamate Receptors in Peripheral Axons of Human Skin. Neuroscience Letters, 283, 149-152. https://doi.org/10.1016/S0304-3940(00)00944-7
[14]
Moharari, R., Najafi, N., Khajavi, M., Moharari, G.S. and Nikoobakht, M.R. (2010) Intraurethral Instillation of Ketamine for Male Rigid Cystoscopy. Journal of Endourology, 24, 2033-2036. https://doi.org/10.1089/end.2010.0193
[15]
Nejati, A., Golshani, K., MoradiLakeh, M., Khashayar, P. and Moharari, R.S. (2010) Ketamine Improves Nasogastric Tube Insertion. Emergency Medicine Journal, 27, 582-585. https://doi.org/10.1136/emj.2009.075275
[16]
El Baradei, S., Tewfik, S.A., Elkhouly, A.H. and Essam, T. (2005) Intraperitoneal Ketamine after Diagnostic Laparoscopic Surgery. Egyptian Journal of Anaesthesia, 21, 141-145.
[17]
Mohamed, S., Sayed, D., El Sherif, F. and Abd El-Rahman, A.M. (2018) Effect of Local Wound Infiltration with Ketamine versus Dexmedetomidine on Postoperative Pain and Stress after Abdominal Hysterectomy, a Randomized Trial. European Journal of Pain, 22, 951-960. https://doi.org/10.1002/ejp.1181
[18]
Safavi, M., Honarmand, A. and Nematollahy, Z. (2011) Pre-Incisional Analgesia with Intravenous or Subcutaneous Infiltration of Ketamine Reduces Postoperative Pain in Patients after Open Cholecystectomy: A Randomized, Double-Blind, Placebo-Controlled Study. Pain Medicine, 12, 1418-1426. https://doi.org/10.1111/j.1526-4637.2011.01205.x
[19]
Javid, M., Rahimi, M. and Keshvari, A. (2011) Dissociative Conscious Sedation, an Alternative to General Anesthesia for Laparoscopic Peritoneal Dialysis Catheter Implantation: A Randomized Trial Comparing Intravenous and Subcutaneous Ketamine. Peritoneal Dialysis International, 31, 308-314. https://doi.org/10.3747/pdi.2010.00110
[20]
Othman, A., Abd El Rahman, A. and El Sherif, F. (2016) Efficacy and Safety of Ketamine Added to Local Anesthetic in the Modified Pectoral Block for Management of Postoperative Pain in Patients Undergoing Modified Radical Mastectomy. Pain Physician, 19, 485-494. https://doi.org/10.36076/ppj/2016.19.485
[21]
Honarmand, A., Safavi, M. and Karaky, H. (2012) Preincisional Administration of Intravenous or Subcutaneous Infiltration of Low-Dose Ketamine Suppresses Postoperative Pain after Appendectomy. Journal of Pain Research, 5, 1-6. https://doi.org/10.2147/JPR.S26476
[22]
Macrae, W.A. (2008) Chronic Post-Surgical Pain: 10 Years On. British Journal of Anaesthesia, 101, 77-86. https://doi.org/10.1093/bja/aen099
[23]
Sng, B.L., Sia, A.T., Quek, K., DWoo, D. and Lim, Y. (2009) Incidence and Risk Factors for Chronic Pain after Cesarean Section under Spinal Anesthesia. Anaesthesia and Intensive Care, 37, 748-752. https://doi.org/10.1177/0310057X0903700513
[24]
Variawa, M.L., Scribante, J., Perrie, H. and Chetty, S. (2016) The Prevalence of Chronic Postmastectomy Pain Syndrome in Female Breast Cancer Survivors. Southern African Journal of Anaesthesia and Analgesia, 22, 108-113. https://doi.org/10.1080/22201181.2016.1191214
[25]
Gammaitoni, A., Gallagher, R.M. and Welz-Bosna, M. (2000) Topical Ketamine Gel: Possible Role in Treating Neuropathic. Pain Medicine, 1, 97-100. https://doi.org/10.1046/j.1526-4637.2000.00006.x
[26]
Crowley, K.L., Flores, J.A., Hughes, C.N. and Iacono, R.P. (1998) Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain. International Journal of Pharmaceutical Compounding, 2, 123-127.
[27]
Mercandanta, S., Lodi, F., Sapio, M., Calligara, M. and Serretta, R. (1995) Long-Term Ketamine Subcutaneous Continuous Infusion in Neuropathic Cancer Pain. Journal of Pain and Symptom Management, 10, 564-568. https://doi.org/10.1016/0885-3924(95)00102-5
[28]
Mahoney, J.M., Vardaxis, V., Moore, J.L., Hall, A.M., Haffner, K.E. and Peterson, M.C. (2012) Topical Ketamine Cream in the Treatment of Painful Diabetic Neuropathy. Journal of the American Podiatric Medical Association, 102, 178-183. https://doi.org/10.7547/1020178
[29]
O’Brien, S.L., Pangarkar, S. and Prager, J. (2014) The Use of Ketamine in Neuropathic Pain. Current Physical Medicine and Rehabilitation Reports, 2, 128-145. https://doi.org/10.1007/s40141-014-0045-2
[30]
Jendoubi, A., Naceur, I.B., Bouzouita, A., Trifa, M., Ghedira, S., Chebil, M. and Houissa, M. (2017) A Comparison between Intravenous Lidocaine and Ketamine on Acute and Chronic Pain after Open Nephrectomy: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study. Saudi Journal of Anaesthesia, 11, 177-184. https://doi.org/10.4103/1658-354X.203027
